| |
DDW/5-2016: Development of a Community-Based Testing (San Diego), Linkage, and Hepatitis C Treatment Program: ....."high prevalence of HCV exposure (20%) and chronic HCV (14%).....Less than half of HCV Ab+ patients had insurance coverage .....SVR12 rates were comparable to large 'real world cohorts'..."
|
| |
| |
Reported by Jules Levin
DDW 2016 May 21-26 San Diego, CA
Christian B. Ramers1,2, Jorge A. Mota2, Robert Lewis2, Letty Reyes2, Danelle Wallace2, Robert Gish3,4, David L. Wyles1, Julio Gutierrez5, Alexander Kuo6
1 Medicine, UC San Diego, San Diego, California, United States; 2 Special Populations, Family Health Centers of San Diego, San Diego, California, United States; 3 Hepatology, Stanford University, Palo Alto, California, United States; 4 Hepatology, St. Joseph's Medical Center, Phoenix, California, United States; 5 Hepatology, Texas Liver Institute, San Antonio, Texas, United States; 6 Hepatology, UC San Diego, San Diego, California, United States
Abstract:
Background: Chronic Hepatitis C virus (HCV) is a major public health concern and the leading chronic viral cause of death in the US. CDC and USPSTF guidelines promote risk-based and birth cohort screening. Community-based testing strategies are needed to identify undiagnosed infections, and new models of care may increase overall treatment capacity.
Methodology: We conducted a rapid testing and linkage to care program within an urban FQHC network and alcohol/drug treatment programs. HIV test counselors were trained on HCV counseling and testing methods. Demographic and clinical data were collected prospectively. Rapid HCV Antibody testing was followed by post-test counseling, confirmatory viral load testing, linkage to care, and treatment when possible.
|
|
| |
| |
|
|
|
